This study concluded that the GATA2 mutations abolishing enhancer-binding resulted in the loss of valves due to reduced expression of PROX1 and FOXC2, and strongly suggests that a loss of valves leads to lymphedema in human patients [34]. Here, GATA2 is linked to lymphedema.